<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Hamilton CA</submitter><funding>Medical Research Council</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>Depressive symptoms are common in mild cognitive impairment (MCI). These may be associated with poorer cognitive function and increased risks of dementia transition.&lt;h4>Aims&lt;/h4>We aimed to examine the cognitive patterns associated with variations in depressive symptoms in neurodegenerative MCI without a primary mood disorder.&lt;h4>Method&lt;/h4>Individuals with MCI (&lt;i>n&lt;/i> = 123), including MCI due to Alzheimer's disease (&lt;i>n&lt;/i> = 54) and MCI with Lewy bodies (&lt;i>n&lt;/i> = 69), underwent repeated annual assessment of cognitive function and concurrent depressive symptoms using the Addenbrooke's Cognitive Examination-Revised and the Geriatric Depression Scale-15, respectively.Between- and within-person differences in depressive symptoms were disaggregated and related to between- and within-person cognitive differences and modification of cognitive performance trajectories over time.&lt;h4>Results&lt;/h4>There was strong evidence of a state-based association between depressive symptoms and cognitive function. Intra-individual differences in depressive symptoms were negatively associated with concurrent cognitive performance such that a 2-point increase in depressive score explained a 1-point decrease in cognitive score, on average (point estimate -0.56, 95% credibile interval (CrI) -1.05 to -0.08).The data did not support a trait-based association between depressive symptoms and cognitive performance (point estimate 0.10, 95% CrI -0.42 to 0.59), nor any between- or within-person trajectory modification associated with depressive symptoms.&lt;h4>Conclusions&lt;/h4>Within-person variations in depressive symptom severity are associated with acute cognitive performance differences. Cognitive scores derived during active depressive periods may underestimate longer-term cognitive capabilities. Treating depressive symptoms in MCI may clarify underlying cognitive performance capacity, and help maintain optimal cognitive function for longer.</pubmed_abstract><journal>The British journal of psychiatry : the journal of mental science</journal><pagination>1-6</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7618092</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Cross-sectional and longitudinal associations between depressive symptoms and cognitive performance in mild cognitive impairment.</pubmed_title><pmcid>PMC7618092</pmcid><funding_grant_id>MR/W000229/1</funding_grant_id><pubmed_authors>Allan LM</pubmed_authors><pubmed_authors>Durcan R</pubmed_authors><pubmed_authors>Hamilton CA</pubmed_authors><pubmed_authors>Firbank M</pubmed_authors><pubmed_authors>Taylor JP</pubmed_authors><pubmed_authors>Greenfinch G</pubmed_authors><pubmed_authors>Donaghy PC</pubmed_authors><pubmed_authors>O'Brien JT</pubmed_authors><pubmed_authors>Ciafone J</pubmed_authors><pubmed_authors>Thomas AJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Cross-sectional and longitudinal associations between depressive symptoms and cognitive performance in mild cognitive impairment.</name><description>&lt;h4>Background&lt;/h4>Depressive symptoms are common in mild cognitive impairment (MCI). These may be associated with poorer cognitive function and increased risks of dementia transition.&lt;h4>Aims&lt;/h4>We aimed to examine the cognitive patterns associated with variations in depressive symptoms in neurodegenerative MCI without a primary mood disorder.&lt;h4>Method&lt;/h4>Individuals with MCI (&lt;i>n&lt;/i> = 123), including MCI due to Alzheimer's disease (&lt;i>n&lt;/i> = 54) and MCI with Lewy bodies (&lt;i>n&lt;/i> = 69), underwent repeated annual assessment of cognitive function and concurrent depressive symptoms using the Addenbrooke's Cognitive Examination-Revised and the Geriatric Depression Scale-15, respectively.Between- and within-person differences in depressive symptoms were disaggregated and related to between- and within-person cognitive differences and modification of cognitive performance trajectories over time.&lt;h4>Results&lt;/h4>There was strong evidence of a state-based association between depressive symptoms and cognitive function. Intra-individual differences in depressive symptoms were negatively associated with concurrent cognitive performance such that a 2-point increase in depressive score explained a 1-point decrease in cognitive score, on average (point estimate -0.56, 95% credibile interval (CrI) -1.05 to -0.08).The data did not support a trait-based association between depressive symptoms and cognitive performance (point estimate 0.10, 95% CrI -0.42 to 0.59), nor any between- or within-person trajectory modification associated with depressive symptoms.&lt;h4>Conclusions&lt;/h4>Within-person variations in depressive symptom severity are associated with acute cognitive performance differences. Cognitive scores derived during active depressive periods may underestimate longer-term cognitive capabilities. Treating depressive symptoms in MCI may clarify underlying cognitive performance capacity, and help maintain optimal cognitive function for longer.</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Aug</publication><modification>2026-06-02T20:22:21.63Z</modification><creation>2026-04-20T03:10:11.228Z</creation></dates><accession>S-EPMC7618092</accession><cross_references><pubmed>40859820</pubmed><doi>10.1192/bjp.2025.10341</doi></cross_references></HashMap>